BrightSpring Health Services, Inc. Common Stock

BrightSpring Health Services, Inc. (NYSE:BTSG) is a Louisville, Kentucky-based healthcare services company that went public in January 2024. Founded in 1974 and formerly known as Phoenix Parent Holdings Inc., the company operates one of the largest home and community-based healthcare platforms in the United States. BrightSpring serves complex patient populations through an integrated network of specialty pharmacies and healthcare providers, focusing on delivering coordinated care in patients' homes and community settings rather than traditional institutional facilities.

Over the past few years, BrightSpring has undergone significant strategic transformation and growth initiatives. The company completed its initial public offering in January 2024, which provided capital for debt reduction and included a notable $100 million equity grant to all employees. This IPO marked a major milestone in the company's evolution from a private equity-owned entity to a public company. The company has pursued aggressive organic growth strategies, particularly in its specialty pharmacy business, where it has expanded its limited distribution drug portfolio from around 100 drugs to 127 as of Q1 2025. Management expects to add approximately 18 new limited distribution drugs over the next 15-18 months, focusing on oncology, rare diseases, and orphan drugs. The specialty pharmacy business has shown remarkable growth, with script volumes increasing 32-36% year-over-year in recent quarters. Strategic acquisitions have been a key growth driver, with the company completing the Haven Hospice acquisition in Florida and maintaining an active pipeline of tuck-in acquisitions in home health, hospice, and rehabilitation services. Management has allocated approximately $100 million annually for M&A activities, targeting deals at around 4x EBITDA multiples. The company has also made significant operational improvements, implementing over 100 procurement and workflow automation programs, investing in artificial intelligence and technology infrastructure, and focusing on quality metrics. Home health branches now achieve 80% four-star or better CMS ratings, and the company maintains industry-leading Net Promoter Scores of 98-100 for its specialty pharmacies. A major strategic decision announced in 2024 was the planned divestiture of the community living business in the second half of 2025, allowing management to focus resources on higher-growth pharmacy and provider services.